Reported 14 days ago
Recent insider trading activity highlights two stocks, Terns Pharmaceuticals and Permian Resources, both of which have seen significant purchases by corporate insiders. Terns is focused on biopharmaceutical developments related to oncology and obesity, while Permian is involved in oil and gas exploration in Texas. Analysts have given both stocks 'Strong Buy' ratings due to their promising prospects, with Terns expected to rise by over 100% and Permian by approximately 37% in the coming year.
Source: YAHOO